Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-10 Purchase |
2023-11-13 5:29 pm |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
25,000 | $2.9638 | $74,095 | 261,966 (Direct) |
View |
| 2023-05-31 Purchase |
2023-06-02 4:15 pm |
Lyra Therapeutics Inc. | LYRA | NBVM GP LLC DAMORE RICHARD A NORTH BRIDGE VENTURE PARTNERS V A LP NORTH BRIDGE VENTURE PARTNERS V-B LP North Bridge Venture Partners VI L P North Bridge Venture Management V L.P. North Bridge Venture Management VI L.P. 10% Owner |
1,805,416 | $2.43 | $4,387,161 | 3,424,453 (Indirect) |
View |
| 2023-05-31 Purchase |
2023-06-02 4:11 pm |
Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner |
1,805,416 | $2.43 | $4,387,161 | 3,542,936 (Indirect Direct) |
View |
| 2023-05-31 Purchase |
2023-06-02 4:11 pm |
Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner |
3,610,832 | $2.4925 | $8,999,999 | 14,562,979 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-08 Option Award |
2025-01-10 4:15 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
800,000 | $0 | 1,100,000 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 4:15 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
420,000 | $0 | 520,000 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 6:54 pm |
N/A 2034-03-20 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
183,333 | $0 | 183,333 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-11 6:39 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
128,333 | $0 | 0 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 4:05 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-10-16 Option Award |
2024-10-18 4:05 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | TOBIN JAMES R Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 4:10 pm |
N/A 2034-06-12 |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-20 7:21 pm |
N/A N/A |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
275,000 | $0 | 536,966 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-20 7:20 pm |
N/A 2034-03-17 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 4:15 pm |
N/A 2034-01-29 |
Lyra Therapeutics Inc. | LYRA | Bishop John E Chief Technology Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 4:15 pm |
N/A 2034-01-29 |
Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 4:15 pm |
N/A 2034-01-29 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-06-15 Option Award(A) |
2023-07-12 6:36 pm |
N/A 2033-06-14 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:53 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | TOBIN JAMES R Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:52 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:50 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:49 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:49 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:46 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:46 pm |
N/A 2033-06-29 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-26 5:39 pm |
N/A 2023-06-14 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-27 Option Award |
2023-02-28 4:10 pm |
N/A 2033-02-26 |
Lyra Therapeutics Inc. | LYRA | Bishop John E Chief Technology Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:41 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP, Technical Operations |
75,000 | $0 | 75,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:19 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:12 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks |
91,667 | $0 | 91,667 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:11 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:09 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:08 pm |
N/A 2033-01-30 |
Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer |
55,537 | $0 | 55,537 (Direct) |
View |
| 2022-07-11 Option Award |
2022-07-12 4:10 pm |
N/A 2032-07-10 |
Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer |
230,000 | $0 | 230,000 (Direct) |
View |